Simeon Schnapper is an early-stage investor focused on the psychedelic and plant medicine sector, backing companies in drug development. See contact routes.
Simeon Schnapper is an early-stage investor focused on the psychedelic and plant medicine sector, backing companies in drug development, treatment centers, cultivation, and digital health infrastructure at Seed and Series A with check sizes of $250,000 to $1 million. His distinctive thesis targets the intersection of psychedelics and technology, selectively investing in consumer wellness ventures like functional mushroom CPG brands and wearables alongside novel molecule discovery. Notable portfolio companies include Myco Systemics (a cultivation firm), Immunis, Wesana Health, and At Life Sciences, reflecting his 30-year commitment to psychedelic research and philanthropy.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Simeon Schnapper · Full investor directory · Investor access · Company funding database